URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.
MINNEAPOLIS, March 5, 2026 /PRNewswire/ — Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) ...
Medical Device Network on MSN
Francis Medical concludes first commercial procedures with Vanquish system
Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
Fernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration ...
CLEVELAND, Oh. - It’s the leading cause of cancer deaths in men 65 and older. Traditional treatment includes chemotherapy, immunotherapy and radiation. Urologist Dr. Ruben Olivares specializes in ...
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...
How a dreaded medical chore is getting a longevity rebrand.
SkinJect Inc., a wholly owned subsidiary of Medicus Pharma Ltd., is a development-stage life sciences company focused on commercializing a novel, non-invasive treatment for basal cell skin cancer ...
SurvivorNet on MSN
Diagnosing muscle-invasive bladder cancer: The initial work-up
When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...
Diagnosed in 2012 with prostate cancer, Tony Minter says his purpose is to share his journey with others. Now in remission, he leads a support group for men newly diagnosed and serves on the board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results